Fluid biomarkers for amyotrophic lateral sclerosis: a review
Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the loss of upper and lower motor neurons. Presently, three FDA-approved drugs are available to help slow functional decline for patients with ALS, but no cure yet exists. With an average life expectan...
| Main Authors: | , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
BMC
2024-01-01
|
| סדרה: | Molecular Neurodegeneration |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s13024-023-00685-6 |